Board of Directors

Peter Rothschild

Chairman of the Board since 2011. Born 1950.

Master of Business Administration from Stockholm School of Economics.

Chairman of the Board of Directors of Annwall & Rothschild Investments AB and Board member of Allbright.
Previously CEO and Chairman of the Board of Directors of BioGaia (publ) and member of the Board of Directors of Moberg Pharma AB (publ).

Shareholding in the Company: 453,283 series A shares and 721,351 series B shares through Annwall & Rothschild Investments AB, a company co-owned with Jan Annwall.

Margareta Hagman

Board member since 2015. Born 1966.

Master of Business Administration, Örebro University.

Since August 2024 CFO at Isofol Medical AB.
Previous positions: CFO and Deputy CEO of BioGaia AB (publ). Has also been active as an advisor and consultant in Economics, Accounting and Finance including interim assignments as CFO at Xbrane BioPharma AB and Ortivus AB.

Shareholding in the Company: 5,284 series B shares.

Anthon Jahreskog

Board member since 2017. Born 1980.

Bachelor’s degree in Management and Systems, City University, London. Master’s degree in Financial Management from the University of Cape Town.

Chairman of the Board of Directors Board Fast Track Holdings Ltd. and board member of BioGaia AB (publ).

Shareholding in the company: 24,270 series B shares.

Eva Idén

Board member since 2017. Born 1966.

Civil Engineer in Chemistry, Chalmers Tekniska Högskola.

Consultant in leadership and organizational development and within the framework of that business owner of Better & Beyond AB and partner and Chairman of Board in Inflecto AB.

Previous positions: Extensive experience in senior management roles at Asta and AstraZeneca.

Shareholding in the company: 560 series B shares.

Kristina Sjöblom Nygren

Board Member since 2018. Born 1961

Kristina is a licensed physician and holds an MD from Karolinska Institutet as well as a Diploma in Pharmaceutical Medicine.

She is Chief Medical Officer, Head of Clinical Development, since May 2021 at Egetis Therapeutics AB (publ) in Stockholm.

Kristina has extensive experience from the pharmaceutical industry, where she has held among other positions Chief Medical Officer, Head Development at Santhera Pharmaceuticals in Basel and Head of Clinical Development at SOBI in Stockholm.

Shareholding in the company: 100 series B shares.